Works matching IS 00778923 AND DT 2011 AND VI 1222 AND IP 1

Results: 14

Linezolid, the first oxazolidinone antibacterial agent.

Published in:

Annals of the New York Academy of Sciences, 2011, v. 1222, n. 1, p. 49, doi. 10.1111/j.1749-6632.2011.05962.x

By:

Leach, Karen L.;
Brickner, Steven J.;
Noe, Mark C.;
Miller, Paul F.

Publication type:

Article

Novartis Malaria Initiative: best practice example of pharmaceutical industry's engagement in the fight against malaria.

Published in:

Annals of the New York Academy of Sciences, 2011, v. 1222, n. 1, p. 19, doi. 10.1111/j.1749-6632.2011.05973.x

By:

Lefèvre, Gilbert;
Marrast, Anne Claire;
Grueninger, Heiner

Publication type:

Article

Foreword by Ban Ki-moon.

Published in:

2011

By:

Ki‐moon, Ban

Publication type:

Other

Development of aprepitant, the first neurokinin-1 receptor antagonist for the prevention of chemotherapy-induced nausea and vomiting.

Published in:

Annals of the New York Academy of Sciences, 2011, v. 1222, n. 1, p. 40, doi. 10.1111/j.1749-6632.2011.05961.x

By:

Hargreaves, Richard;
Ferreira, Juan Camilo Arjona;
Hughes, David;
Brands, Jos;
Hale, Jeff;
Mattson, Britta;
Mills, Sandy

Publication type:

Article

Raltegravir: the first HIV-1 integrase strand transfer inhibitor in the HIV armamentarium.

Published in:

Annals of the New York Academy of Sciences, 2011, v. 1222, n. 1, p. 83, doi. 10.1111/j.1749-6632.2011.05972.x

By:

Nguyen, Bach‐Yen T.;
Isaacs, Robin D.;
Teppler, Hedy;
Leavitt, Randi Y.;
Sklar, Peter;
Iwamoto, Marian;
Wenning, Larissa A.;
Miller, Michael D.;
Chen, Joshua;
Kemp, Ramon;
Xu, Wei;
Fromtling, Robert A.;
Vacca, Joseph P.;
Young, Steven D.;
Rowley, Michael;
Lower, Michael W.;
Gottesdiener, Keith M.;
Hazuda, Daria J.

Publication type:

Article

Innovation in coronary artery disease and heart failure: clinical benefits of pure heart rate reduction with ivabradine.

Published in:

Annals of the New York Academy of Sciences, 2011, v. 1222, n. 1, p. 90, doi. 10.1111/j.1749-6632.2011.05960.x

By:

Canet, Emmanuel;
Lerebours, Guy;
Vilaine, Jean‐Paul

Publication type:

Article

The discovery and development of rivaroxaban.

Published in:

Annals of the New York Academy of Sciences, 2011, v. 1222, n. 1, p. 64, doi. 10.1111/j.1749-6632.2011.05971.x

By:

Misselwitz, Frank;
Berkowitz, Scott D.;
Perzborn, Elisabeth

Publication type:

Article

Advances in the diagnosis of respiratory tract infections: role of the Luminex xTAG respiratory viral panel.

Published in:

Annals of the New York Academy of Sciences, 2011, v. 1222, n. 1, p. 6, doi. 10.1111/j.1749-6632.2011.05964.x

By:

Krunic, Nancy;
Merante, Frank;
Yaghoubian, Sevana;
Himsworth, David;
Janeczko, Richard

Publication type:

Article

The development of romiplostim for patients with immune thrombocytopenia.

Published in:

Annals of the New York Academy of Sciences, 2011, v. 1222, n. 1, p. 55, doi. 10.1111/j.1749-6632.2011.05975.x

By:

Molineux, Graham

Publication type:

Article

Prix Galien Pro Bono Humanitarian Award Winner: Philippe Douste-Blazy.

Published in:

Annals of the New York Academy of Sciences, 2011, v. 1222, n. 1, p. 1, doi. 10.1111/j.1749-6632.2011.05997.x

By:

Douste‐Blazy, Philippe

Publication type:

Article

Development, clinical evaluation, and post-licensure impact of RotaTeq, a pentavalent rotavirus vaccine.

Published in:

Annals of the New York Academy of Sciences, 2011, v. 1222, n. 1, p. 14, doi. 10.1111/j.1749-6632.2011.05970.x

By:

Goveia, Michelle G.;
Ciarlet, Max;
Owen, Katey E.;
Ranucci, Colette S.

Publication type:

Article

Development of the IL-12/23 antagonist ustekinumab in psoriasis: past, present, and future perspectives.

Published in:

Annals of the New York Academy of Sciences, 2011, v. 1222, n. 1, p. 30, doi. 10.1111/j.1749-6632.2011.05963.x

By:

Yeilding, Newman;
Szapary, Philippe;
Brodmerkel, Carrie;
Benson, Jacqueline;
Plotnick, Michael;
Zhou, Honghui;
Goyal, Kavitha;
Schenkel, Brad;
Giles‐Komar, Jill;
Mascelli, Mary Ann;
Guzzo, Cynthia

Publication type:

Article

A review of the history, properties, and use of the immunomodulatory compound lenalidomide.

Published in:

Annals of the New York Academy of Sciences, 2011, v. 1222, n. 1, p. 76, doi. 10.1111/j.1749-6632.2011.05974.x

By:

Zeldis, Jerome B.;
Knight, Robert;
Hussein, Mohamad;
Chopra, Rajesh;
Muller, George

Publication type:

Article

Prix Galien Pro Bono Humanitarian Award Winner: William J. Clinton.

Published in:

Annals of the New York Academy of Sciences, 2011, v. 1222, n. 1, p. 3, doi. 10.1111/j.1749-6632.2011.05996.x

By:

Clinton, William J.

Publication type:

Article